The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders

Autor: Hu, Tjing-Tjing, Vanhove, Marc, Porcu, Michaël, Van Hove, Inge, Van Bergen, Tine, Jonckx, Bart, Barbeaux, Philippe, Vermassen, Elke, Feyen, Jean H.M.
Zdroj: In Experimental Eye Research March 2019 180:43-52
Databáze: ScienceDirect